Heim3692 • HKG
add
Hansoh Pharmaceutical Group Company Ltd
Við síðustu lokun
21,00 $
Dagbil
20,75 $ - 22,15 $
Árabil
10,90 $ - 22,80 $
Markaðsvirði
130,88 ma. HKD
Meðalmagn
8,81 m.
V/H-hlutf.
25,76
A/V-hlutfall
1,56%
Aðalkauphöll
HKG
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CNY) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 3,25 ma. | 44,21% |
Rekstrarkostnaður | 1,66 ma. | 12,83% |
Nettótekjur | 1,36 ma. | 111,47% |
Hagnaðarhlutfall | 41,90 | 46,66% |
Hagnaður á hvern hlut | — | — |
EBITDA | 1,40 ma. | 131,62% |
Virkt skatthlutfall | 12,59% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CNY) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 23,50 ma. | -0,16% |
Heildareignir | 31,67 ma. | -0,84% |
Heildarskuldir | 3,77 ma. | -51,47% |
Eigið fé alls | 27,90 ma. | — |
Útistandandi hlutabréf | 5,93 ma. | — |
Eiginfjárgengi | 4,47 | — |
Arðsemi eigna | 10,25% | — |
Ávöxtun eigin fjár | 11,58% | — |
Peningaflæði
Breyting á handbæru fé
| (CNY) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 1,36 ma. | 111,47% |
Handbært fé frá rekstri | 1,34 ma. | 134,03% |
Reiðufé frá fjárfestingum | 1,18 ma. | 127,37% |
Reiðufé frá fjármögnun | -2,10 ma. | -8.216,31% |
Breyting á handbæru fé | 407,85 m. | -60,50% |
Frjálst peningaflæði | 778,25 m. | 121,05% |
Um
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Stofnsett
1995
Vefsvæði
Starfsfólk
9.099
